Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Esophageal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Malignant Solid Neoplasm 1Lymphoma 1Lung Neoplasms 1Hematologic Neoplasms 1Glioma 1Endometrial Neoplasms 1Endometrial Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Bladder Urothelial Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Tamoxifen 6Specimen Handling 4Neoadjuvant Therapy 3Radiotherapy 2Chemotherapy, Adjuvant 2Biopsy 2Anastrozole 2trastuzumab biosimilar HLX02 1sargramostim 1exemestane 1UAB 30 1Trastuzumab 1Surgical Procedures, Operative 1Sulindac 1Polymerase Chain Reaction 1PF-05280014 1Ontruzant 1Omacor 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Lapatinib 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Immunoenzyme Techniques 1High-Energy Shock Waves 1HER2 peptide (369-377) 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fulvestrant 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma, Intraductal, Noninfiltrating × trastuzumab biosimilar HLX02 × Clear all
NCT00769379 2025-06-12

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

National Cancer Institute (NCI)

Phase 3 Completed
2,014 enrolled 16 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡